{"brief_title": "Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder", "brief_summary": "The purposes of this study are to determine: - The effectiveness of olanzapine as compared to quetiapine in treating and preventing the recurrence of a variety of symptoms of schizophrenia and schizoaffective disorder in patients who are obese or overweight. - The safety of olanzapine as compared to quetiapine.", "condition": ["Schizophrenia", "Schizoaffective Disorder"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Olanzapine", "Quetiapine"], "criteria": "Inclusion Criteria: - You must be 18-75 years of age and be diagnosed with schizophrenia or schizoaffective disorder - You must be able to visit the doctor's office thirteen (13) times over a twenty-six (26) week period Exclusion Criteria: - You are a woman and are pregnant or breastfeeding - You have an acute or unstable medical illness, such as heart, liver, or kidney disease, or you have a seizure disorder. (Note: If you are uncertain about a particular condition, please discuss it with your physician.) - You have a history of allergic reaction or intolerance to olanzapine or quetiapine", "gender": "All", "minimum_age": "18 Years", "maximum_age": "75 Years", "healthy_volunteers": "No", "mesh_term": ["Disease", "Schizophrenia", "Overweight", "Psychotic Disorders", "Quetiapine Fumarate", "Olanzapine"], "id": "NCT00090012"}